Adipose tissue expression of 11beta-Hydroxysteroid dehydrogenase type 1 in cushing's syndrome and in obesity
Open Access
- 1 November 2007
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Archives of Endocrinology and Metabolism
- Vol. 51 (8) , 1397-1403
Abstract
Glucocorticoids have a major role in determining adipose tissue metabolism and distribution. 11beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) is a NADPH-dependent enzyme highly expressed in the liver and adipose tissue. In most intact cells and tissues it functions as a reductase (to convert inactive cortisone to active cortisol). It has been hypothesized that tissue-specific deregulation of cortisol metabolism may be involved in the complex pathophysiology of the metabolic syndrome (MS) and obesity. Transgenic mice overexpressing 11betaHSD1 in adipose tissue develop obesity with all features of the MS, whereas 11betaHSD1-knockout mice are protected from both. The bulk of evidences points to an overexpression and increased activity of 11betaHSD1 also in human adipose tissue. However, 11betaHSD1 seems to adjust local cortisol concentrations independently of its plasma levels. In Cushing's syndrome, 11betaHSD1 is downregulated and may not be responsible for the abdominal fat depots; it also undergoes downregulation in response to weight loss in human obesity. The nonselective 11betaHSD1 inhibitor carbenoxolone improves insulin sensitivity in humans, and selective inhibitors enhance insulin action in diabetic mice liver, thereby lowering blood glucose. Thus, 11betaHSD1 is now emerging as a modulator of energy partitioning and a promising pharmacological target to treat the MS and diabetes.Keywords
This publication has 43 references indexed in Scilit:
- Extra-adrenal regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioningProceedings of the Nutrition Society, 2007
- 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in miceJournal of Experimental Medicine, 2005
- Interaction Between an 11βHSD1 Gene Variant and Birth Era Modifies the Risk of Hypertension in Pima IndiansHypertension, 2004
- 11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memoryTrends in Endocrinology & Metabolism, 2004
- Regulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight LossObesity Research, 2004
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- The Activity of the Hypothalamic‐Pituitary‐Adrenal Axis and the Sympathetic Nervous System in Relation to Waist/Hip Circumference Ratio in MenObesity Research, 2000
- Inhibition of Cortisol Secretion by Dexamethasone in Relation to Body Fat Distribution: A Dose‐Response StudyObesity Research, 1996
- Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndromeMetabolism, 1994
- Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo : further evidence for the existence of a second dehydrogenase in rat kidneyJournal of Endocrinology, 1993